Xpert in Biological Technology

Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System

License Enables Access to Canadian HAI Market; Market Expenditures for MRSA Surveillance Expected to Reach $80 Million by 2012 SUNNYVALE, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that Health Canada has issued a medical device license for the Xper...

New England Journal of Medicine Study Highlights Need for Rapid, PCR-based Group B Streptococcus (GBS) Testing at Time of Admission for Labor and Delivery

... test to fully meet current CDC criteria for rapid intrapartum GBS testing. xpert GBS is also the only PCR-based antepartum and intrapartum GBS test to recei...rses to run the test near-patient -- 24 hours a day, 365 days a year. xpert GBS runs on Cepheid's GeneXpert(R) System, the world's leading on-demand mo...

Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

...ycobacterium tuberculosis - a product that, in my opinion, is one of the most important diagnostic developments to have occurred in many years." xpert MTB/RIF not only detects the presence of TB organism directly from sputum in less than two hours, but also identifies whether the strain is resistant ...

Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)

...cs and this capability is on full display with the xpert MTB/RIF test. Clinicians will now be able to obtai...trains of tuberculosis and the availability of the xpert MTB/RIF test should be a breakthrough technologica...ailable as a CE IVD Mark product next month." xpert MTB/RIF not only detects the presence of TB, but a...

Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results

... for the fourth quarter of 2008, which compares to xpert MRSA test revenue of approximately $5 million repo...in the fourth quarter of 2007. For the full year, xpert MRSA test revenue is expected to be approximately ...rest in our GeneXpert system and expanding menu of xpert tests continues to grow, ongoing economic turbulen...

Dorset County Hospital Enhances MRSA Surveillance Programme Through Rapid Patient Screening

...ctor of Nursing and Infection Prevention and Control, says, "We are always looking for new ways to further prevent infection and improve patient care. xpert MRSA rapid screening technology will vastly reduce the risks to patients admitted to Dorset County Hospital and I hope will provide further reassuranc...

Cepheid Reports Third Quarter Revenue of $44.9 Million

...otal revenue to be in the range of $174 to $176 million, of which product sales are expected to be in the range of $164 to $166 million. o xpert MRSA test sales are expected to be in the range of $49 to $51 million. -- Net loss for 2008 is expected to be in the range of $22.5 to ...

Results of United Kingdom MRSA Surveillance Program Using Cepheid GeneXpert(R) System Demonstrate Benefits of Rapid Testing

... doctors at the hospital to identify MRSA carriers in under an hour. To validate the 100 percent accuracy rate of the on-demand results obtained using xpert MRSA, all results so far have been verified with a traditional culture-based test, which takes up to three days for results. The hospital has already ...

Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized 'Moderate Complexity' by FDA

... (SA), (typically Methicillin-sensitive) in SSTIs. xpert MRSA/SA SSTI runs on Cepheid's GeneXpert(R) System...s). Cleared by the FDA for marketing last month, xpert MRSA/SA SSTI is the first molecular SSTI diagnosti...ls throughout the U.S. "The value proposition of xpert MRSA/SA SSTI is resonating well with physicians an...

Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures

...sitive cocci -- in less than one hour. Cepheid's xpert MRSA/SA BC test processes positive blood culture s...ntibiotics altogether. "With the addition of our xpert MRSA/SA Blood Culture diagnostic test, Cepheid is ...atients are five times as likely to be outliers. xpert MRSA/SA BC delivers on-demand test results to assi...

Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus

...ive) in skin and soft tissue infections. In less than one hour, Cepheid's xpert MRSA/SA SSTI test processes specimens from suspected skin and soft tissue i...stay is 18 days following a MRSA infection and 9 days for a SA infection. xpert MRSA/SA SSTI delivers actionable test results to assist physicians and surg...

Cepheid Reports Second Quarter Revenue of $42.1 Million

...Total revenue to be in the range of $173 to $177 million, of which product sales are expected to be in the range of $164 to $167 million. o xpert MRSA test sales are expected to be in the range of $52 to $55 million. -- Net loss for 2008 is expected to be in the range of $20 to $22 ...

Cepheid Market Reach Extended with Licenses in Canada and Registrations in Mexico

...tion of EV-associated meningitis. These tests join xpert MRSA, which received Health Canada license in Janu...ealth for its GeneXpert System and Xpert(TM) MRSA, xpert GBS and xpert EV tests. The products will be distributed exclusi...

Cepheid Signs Group Purchasing Contract with Novation, the Nation's Largest Healthcare Contracting Organization

...ection rates have increased every year since 1970. xpert MRSA test results are currently available in appro...test results to the floor. The availability of the xpert MRSA test and the GeneXpert System is expected to ...r HAI rates and improved patient care. On-demand xpert MRSA results enable healthcare professionals to ra...

Cepheid Reports Fourth Quarter and Full Year 2007 Results

...f 2,569 modules in Europe and the U.S. now running xpert tests. Within the U.S., 88 of 247 system placement... and 2.2 respectively from September 30, 2007. New xpert MRSA accounts typically take approximately six wee...eneXpert System and Xpert line of tests, including xpert MRSA. In January 2008, Cepheid began shipment of...

Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market

...ostics company, today announced the release of the xpert (TM) HemosIL(R) FII & FV assay as a European CE IV... minutes with a single GeneXpert(R) cartridge, the xpert HemosIL FII & FV assay detects Factor II (FII) and...gh IL, the exclusive worldwide distributor for the xpert HemosIL FII & FV assay. ...